MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0094603
Vetecura Life Sciences Private Limited
Vetecura Life Sciences Private Limited - pharma in Ulhasnagar, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹15.71 Cr
▲ 52% YoY
Net profit · FY 2025
₹52.05 Lakh
Net margin 3.3%
EBITDA · FY 2025
₹1.07 Cr
EBITDA margin 6.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
Active GSTINs
3
GST registered
About Vetecura Life Sciences Private Limited
Data last updated:
Vetecura Life Sciences Private Limited is a private limited company based in Ulhasnagar, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24302MH2018PTC312731. Its GSTIN is 27AAGCV5378K1ZN (Maharashtra). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ashwini Venkatramulu Koli and Prashant Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ulhasnagar, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.71 Cr, a growth of 52% compared to the previous year. For the same year it recorded a net profit of ₹52.05 Lakh (net margin 3.3%) and EBITDA of ₹1.07 Cr (EBITDA margin 6.8%). Revenue has grown at a compounded annual rate (CAGR) of 86% over three years and 335% over five years.
Vetecura Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0094603).
Company details
CIN U24302MH2018PTC312731
Registration Number 312731
Incorporation Date 13 August 2018
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-MH-33-0094603
Key People
Ashwini Venkatramulu Koli Director Prashant Kumar Singh Director Vishal Satish Surve Director Recognitions & Rankings of Vetecura Life Sciences
Contact details
Vetecura Life Sciences Private Limited's registered office is in Ulhasnagar, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No C – 02 Ground Floor Regency Plaza 2 Coop Premises Near Valdhuni Bridge Shantina, Gar, Ulhasnagar, Maharashtra, India – 421003
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Vetecura Life Sciences Private Limited, buy the company report.
Comprehensive company report
Vetecura Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vetecura Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Vetecura Life Sciences Private Limited, buy the company report.
Financials of Vetecura Life Sciences Private Limited
FY 2025 filings availableVetecura Life Sciences Private Limited reported revenue of ₹15.71 Cr (up 52% YoY) for FY 2025.
Revenue · FY 2025
₹15.71 Cr ▲ 52%
Net profit · FY 2025
₹52.05 Lakh margin 3.3%
EBITDA · FY 2025
₹1.07 Cr margin 6.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 52%
3 years · compounded
▲ 86%
5 years · compounded
▲ 335%
EBITDA CAGR growth
1 year
▲ 63%
3 years · compounded
▲ 142%
5 years · compounded
▲ 163%
Revenue has grown at a compounded annual rate (CAGR) of 335% over five years, including 52% growth in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.07 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹52.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | ||||
| Net Profit Margin | 3.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vetecura Life Sciences Private Limited, buy the company report.
Board of directors of Vetecura Life Sciences Private Limited
Vetecura Life Sciences has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashwini Venkatramulu Koli Also directs: Horus International Private Limited | Director | 01 Mar 2020 | 6 Years 7 Months | Current |
| Prashant Kumar Singh | Director | 01 Mar 2020 | 6 Years 7 Months | Current |
| Vishal Satish Surve Also directs: Shivanshi Giftcraft LLP, Earth Smartpet LLP, Bionex Vetcare Private Limited and 2 more | Director | 01 Mar 2020 | 6 Years 7 Months | Current |
Peer comparison
Vetecura Life Sciences Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biorex Healthcare Private Limited | ₹15.77 Cr (FY 2024) | 25.0% | New Delhi, Delhi, India | |||
| TTG Innovations Private Limited | ₹15.76 Cr (FY 2025) | 42.0% | Delhi, India | |||
| Vetecura Life Sciences Private Limitedthis company | ₹15.71 Cr (FY 2025) | ₹52.05 Lakh | 3.3% | 52.0% | Ulhasnagar, Maharashtra, India | |
| Leeford Medicare Limited | ₹15.69 Cr (FY 2025) | 11.0% | Ludhiana, Punjab, India | |||
| Farlex Pharmaceuticals Private Limited | ₹15.67 Cr (FY 2025) | 25.0% | Manimajra, Chandigarh, India | |||
| Medtech Pharma (India) Private Limited | ₹15.61 Cr (FY 2025) | 21.0% | New Delhi, Delhi, India |
To see the full peer comparison of Vetecura Life Sciences Private Limited, buy the company report.
Auditor
Vetecura Life Sciences Private Limited is audited by SARANGDHAR AND CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SARANGDHAR AND CO. | FY 2023 | 109254W |
Shareholding
The shareholding of Vetecura Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vetecura Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Vetecura Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vetecura Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vetecura Life Sciences has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCV5378K1ZN | Maharashtra | Active | 23 Jan 2019 |
| 29AAGCV5378K1ZJ | Karnataka | Active | 16 Aug 2025 |
| 07AAGCV5378K1ZP | Delhi | Active | 21 Nov 2025 |
To see the full GST registrations and return filing status of Vetecura Life Sciences Private Limited, buy the company report.
Recent activity
Vetecura Life Sciences Private Limited has 13 board changes on record since 2018: 8 appointments and 5 cessations. The latest: Anita Prakash Manik ceased to be Additional Director on 24 Feb 2023.
AGM
Vetecura Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vetecura Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Ceased
Anita Prakash Manik ceased to be Additional Director.
Appointed
Anita Prakash Manik was appointed as Additional Director.
Ceased
Ganesh Ramdas Ghangale ceased to be Director.
Appointed
Ashwini Venkatramulu Koli was appointed as Director.
Ceased
Harshal Satish Surve ceased to be Director.
Appointed
Prashant Kumar Singh was appointed as Director.
Ceased
Sita Kumari Prashant Kumar Singh ceased to be Additional Director.
Appointed
Vishal Satish Surve was appointed as Director.
Ceased
Shilpy Anupama Minz ceased to be Director.
Appointed
Sita Kumari Prashant Kumar Singh was appointed as Additional Director.
4 earlier events are in the company report.
Frequently asked questions
Vetecura Life Sciences is an active private limited company based in Ulhasnagar, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 August 2018 (8+ years old) and is registered under CIN U24302MH2018PTC312731.
Vetecura Life Sciences has 3 current directors:
- Ashwini Venkatramulu Koli - Director
- Prashant Kumar Singh - Director
- Vishal Satish Surve - Director
The latest financial statements of Vetecura Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Vetecura Life Sciences is 27AAGCV5378K1ZN, registered in Maharashtra. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 29AAGCV5378K1ZJ (Karnataka), 07AAGCV5378K1ZP (Delhi).
The CIN (Corporate Identification Number) of Vetecura Life Sciences is U24302MH2018PTC312731. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vetecura Life Sciences was incorporated on 13 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Vetecura Life Sciences by revenue are Biorex Healthcare Private Limited, TTG Innovations Private Limited, Leeford Medicare Limited, Farlex Pharmaceuticals Private Limited, Medtech Pharma (India) Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Anita Prakash Manik ceased to be Additional Director on 24 Feb 2023. Anita Prakash Manik was appointed as Additional Director on 16 Jun 2022. Ganesh Ramdas Ghangale ceased to be Director on 13 Oct 2021. Vetecura Life Sciences has 13 board changes on record in total.
Yes, Vetecura Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0094603).
The registered office of Vetecura Life Sciences is at Shop No C – 02 Ground Floor Regency Plaza 2 Coop Premises Near Valdhuni Bridge Shantina, Gar, Ulhasnagar, Maharashtra, India – 421003.
Vetecura Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages